Related Experiment Video

Updated: Nov 10, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.6K

Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia

Oriol de Barrios1, Maribel Parra1

  • 1Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles s/n, 08916 Barcelona, Spain.

International Journal of Molecular Sciences
|April 3, 2021
PubMed

Insights

Epigenetic alterations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) disrupt normal B lymphocyte development. Understanding these changes, including DNA methylation and histone modifications, is crucial for improving infant prognosis and therapeutic strategies.

Area of Science:

  • Oncology
  • Epigenetics
  • Hematology

Background:

  • B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is an aggressive childhood cancer with a poor prognosis, particularly in infants.
  • Leukemogenesis in BCP-ALL is often driven by genetic alterations affecting embryonic genes and chromatin remodelers.
  • Epigenetic dysregulation, involving DNA and histone modifications, plays a critical role in BCP-ALL development.

Purpose of the Study:

  • To review the impact of epigenetic alterations on BCP-ALL pathogenesis.
  • To explore how aberrant epigenetic profiles modulate oncogenic drivers and tumor suppressors.
  • To highlight the importance of integrated epigenetic knowledge for therapeutic advancements.

Main Methods:

  • Review of existing literature on epigenetic mechanisms in BCP-ALL.
  • Analysis of DNA methylation patterns and their correlation with survival.
  • Examination of histone modifications, including methylation and acetylation, and their functional consequences.

Main Results:

  • Altered DNA methylation patterns in BCP-ALL are linked to patient survival.
  • Histone modifications, such as altered H3K4 and H3K79 methylation due to KMT2A rearrangements, enhance oncogene activation and worsen infant outcomes.
  • Acetylation processes further contribute to chromatin alterations, influencing regulatory factor binding.

Conclusions:

  • Integrated understanding of DNA and histone epigenetic disorders is essential for comprehending BCP-ALL.
  • Targeting epigenetic dysregulation offers potential for novel therapeutic strategies and improved prognosis in BCP-ALL.
  • Further research into epigenetic mechanisms can identify new therapeutic entry points for BCP-ALL treatment.

Keywords:
B lymphocytesacute lymphoblastic leukemiaepigenetics

More Related Videos

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

18.4K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.2K

Related Concept Videos

Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
7.3K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.6K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.9K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
565
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.9K